Sunshine Biopharma Discusses The Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast episode artwork

EPISODE · Feb 17, 2021 · 9 MIN

Sunshine Biopharma Discusses The Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast

from Stock Day Media · host Stock Day Media

The Stock Day Podcast welcomed Sunshine Biopharma (SBFM)(“the Company”), a company engaged in the development of Adva-27a, a unique anticancer compound, as well as the development of a treatment for COVID-19. CEO of the Company, Dr. Steve Slilaty, joined Stock Day host Everett Jolly.  Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Feb 17, 2021

Embed this episode

NOW PLAYING

Sunshine Biopharma Discusses The Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast

0:00 9:36

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 9 minutes long.

When was this Stock Day Media episode published?

This episode was published on February 17, 2021.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!